Published in Phytomedicine on January 01, 2005
The pharmacokinetics of anthocyanins and their metabolites in humans. Br J Pharmacol (2014) 1.00
Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production. J Cell Mol Med (2008) 0.97
Intestinal transit and systemic metabolism of apple polyphenols. Eur J Nutr (2010) 0.84
Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid. Toxins (Basel) (2016) 0.81
Endogenous enzymes, heat, and pH affect flavone profiles in parsley (Petroselinum crispum var. neapolitanum) and celery (Apium graveolens) during juice processing. J Agric Food Chem (2011) 0.81
Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers. BMC Clin Pharmacol (2006) 0.79
Absorption and isomerization of caffeoylquinic acids from different foods using ileostomist volunteers. Eur J Nutr (2013) 0.76
Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice. J Neuroimmunol (2016) 0.75
The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis. Int J Hepatol (2016) 0.75
Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity. Adv Nutr (2017) 0.75
Protective Effects of Ethanolic Extracts from Artichoke, an Edible Herbal Medicine, against Acute Alcohol-Induced Liver Injury in Mice. Nutrients (2017) 0.75
Acute effects of light and dark roasted coffee on glucose tolerance: a randomized, controlled crossover trial in healthy volunteers. Eur J Nutr (2015) 0.75
Bimodal interaction of coatomer with the p24 family of putative cargo receptors. Science (1996) 2.76
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07
Acoustic and mechanical properties of artificial stones in comparison to natural kidney stones. J Urol (2000) 2.05
MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer (1997) 2.04
Grapefruit-drug interactions: can interactions with drugs be avoided? J Clin Pharmacol (2006) 1.82
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol (2000) 1.58
Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol (2001) 1.57
New agents for treatment of advanced transitional cell carcinoma. Ann Oncol (2006) 1.53
AUIC--a general target for the optimization of dosing regimens of antibiotics? Ann Pharmacother (1996) 1.51
The buccal mucosal graft for urethral reconstruction: a preliminary report. J Urol (1992) 1.49
Idiopathic anterior urethritis in prepubertal and pubertal boys: pathology and clues to etiology. Urology (1998) 1.47
Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs. J Pharm Sci (1992) 1.45
Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology. Eur Respir J (2001) 1.43
Ileocecal valve reconstruction during continent urinary diversion. J Urol (1994) 1.41
[Pancreatic penetration of antibiotics]. Chirurg (1991) 1.40
Long-term results of internal urethrotomy. J Urol (1996) 1.39
Curvature and propagation velocity of chemical waves. Science (1988) 1.38
Microdialysis in peripheral tissues. Adv Drug Deliv Rev (2000) 1.35
Microdialysis. A novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol (2001) 1.34
Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther (1986) 1.32
Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life. Onkologie (2002) 1.28
Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol (2000) 1.26
Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Int J Clin Pharmacol Ther (1997) 1.25
Traveling NADH and proton waves during oscillatory glycolysis in vitro. J Biol Chem (1996) 1.21
Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii. J Parasitol (1994) 1.20
Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160. J Geriatr Psychiatry Neurol (1994) 1.18
Spatial patterns from oscillating microtubules. Science (1989) 1.17
Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis (2007) 1.17
Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. Eur J Clin Pharmacol (1998) 1.17
Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications. Clin Pharmacokinet (1998) 1.17
Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model. J Clin Pharmacol (1997) 1.16
Comparative study on photosynthetic activity of chloroplasts in acid and alkaline zones of Chara corallina. Bioelectrochemistry (2001) 1.15
Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. Planta Med (2000) 1.15
Kidney's nightshift, kidney's nightmare? Comparison of daylight and nighttime kidney transplantation: impact on complications and graft survival. Transplant Proc (2008) 1.15
Chemical waves. Science (1988) 1.14
Light-triggered pH banding profile in Chara cells revealed with a scanning pH microprobe and its relation to self-organization phenomena. J Theor Biol (2001) 1.08
Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Klin Wochenschr (1988) 1.04
Population pharmacokinetics of intramuscular quinine in children with severe malaria. Antimicrob Agents Chemother (2001) 1.04
Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittelforschung (1996) 1.04
Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment. Virology (1995) 1.03
The structure of the core of the spiral wave in the belousov-zhabotinskii reaction. Science (1985) 1.03
Increased expression of connexin 43 in the overactive neurogenic detrusor. Eur Urol (2004) 1.03
Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats. Pharm Res (2001) 1.02
The Mainz pouch II (sigma rectum pouch). J Urol (1993) 1.01
Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. J Urol (1992) 1.00
Pharmacokinetic-pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro. Pharm Res (1996) 0.99
A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother (2000) 0.99
Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis. J Antimicrob Chemother (1998) 0.98
[Indications for nuclear medicine therapy in advanced prostate carcinoma]. Urologe A (1998) 0.98
Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate. J Clin Pharmacol (1996) 0.98
Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther (1999) 0.97
Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. J Pharm Sci (1997) 0.97
Image processing techniques applied to excitation waves in the chicken retina. Methods (2000) 0.97
Rotating spiral waves created by geometry. Science (1994) 0.96
Adenovirus death protein, a transmembrane protein encoded in the E3 region, is palmitoylated at the cytoplasmic tail. Virology (1998) 0.96
Self-induced splitting of spiral-shaped spreading depression waves in chicken retina. Exp Brain Res (1997) 0.96
Transitions from alkaline spots to regular bands during pH pattern formation at the plasmalemma of Chara cells. Eur Biophys J (2003) 0.95
Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol (2004) 0.95
A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma. J Pharm Biomed Anal (2000) 0.95
Retarded processing of influenza virus hemagglutinin in insect cells. Virology (1991) 0.95
Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J Vet Pharmacol Ther (1998) 0.94
Plant polyketide synthases: a chalcone synthase-type enzyme which performs a condensation reaction with methylmalonyl-CoA in the biosynthesis of C-methylated chalcones. Biochemistry (1998) 0.94
Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther (2003) 0.94
Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int J Clin Pharmacol Ther (1999) 0.94
Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations. Int J Clin Pharmacol Ther (1997) 0.93
Dependency of cortisol suppression on the administration time of inhaled corticosteroids. J Clin Pharmacol (1997) 0.93
A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids. J Pharmacokinet Biopharm (1999) 0.92
An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy. AAPS PharmSci (2000) 0.92
Determination of free extracellular concentrations of piperacillin by microdialysis. J Pharm Sci (1996) 0.92
Pharmacokinetics of triamcinolone acetonide and its phosphate ester. Eur J Clin Pharmacol (1985) 0.92
Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies. Ther Drug Monit (1993) 0.91
Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. Clin Chem (1992) 0.90
Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (2001) 0.90
5-HT3 receptor blocking activity of arylalkanes isolated from the rhizome of Zingiber officinale. Planta Med (2005) 0.90
Primary extraskeletal osteosarcoma of the glans penis and glanular reconstruction. BJU Int (2003) 0.90
Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects. J Clin Pharmacol (2001) 0.89
Three-dimensional waves of excitation during Dictyostelium morphogenesis. Proc Natl Acad Sci U S A (1993) 0.89
Comparison of inguinal approach, scrotal sclerotherapy and subinguinal antegrade sclerotherapy in varicocele treatment: a randomized prospective study. Urol Int (2010) 0.89
Biowaiver monographs for immediate release solid oral dosage forms: prednisolone. J Pharm Sci (2007) 0.89
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections. Eur J Clin Pharmacol (2008) 0.89
Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob Agents Chemother (1996) 0.88
The fate of the adult exstrophy patient. J Urol (1994) 0.88
Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids. J Chromatogr (1985) 0.88
Interpretation of absorption rate data for inhaled fluticasone propionate obtained in compartmental pharmacokinetic modeling. Int J Clin Pharmacol Ther (2005) 0.88
Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. Eur J Med Res (2002) 0.87
Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects. Ther Drug Monit (1986) 0.87
Critical size and curvature of wave formation in an excitable chemical medium. Proc Natl Acad Sci U S A (1989) 0.87
Kinetics of methylprednisolone and its hemisuccinate ester. Clin Pharmacol Ther (1985) 0.87
Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol (2000) 0.86
Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin. Int J Clin Pract (2006) 0.86
The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing pancreatitis. Infection (2001) 0.86
Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration. J Clin Pharmacol (1997) 0.86
Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites. Phytomedicine (2002) 0.86
[Detection of cell-free lncRNA in serum of cancer patients]. Urologe A (2015) 0.86
Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans. Br J Clin Pharmacol (1999) 0.85
Desensitization of brain opiate receptor mechanisms by gonadal steroid treatments that stimulate luteinizing hormone secretion. Endocrinology (1988) 0.85